Lowe's Companies Total Cost of Revenue increased by 11.7% to $15.54B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.4%, from $13.94B to $15.54B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows a downward trend with a -2.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.29B | $18.26B | $15.33B | $14.31B | $15.61B | $18.34B | $15.66B | $15.19B | $14.82B | $16.56B | $13.58B | $12.58B | $14.27B | $15.69B | $13.37B | $12.46B | $13.94B | $15.86B | $13.70B | $13.90B | $15.54B |
| QoQ Change | — | +12.1% | -16.0% | -6.6% | +9.1% | +17.5% | -14.6% | -3.0% | -2.4% | +11.7% | -18.0% | -7.4% | +13.5% | +9.9% | -14.8% | -6.8% | +11.9% | +13.7% | -13.6% | +1.5% | +11.7% |
| YoY Change | — | — | — | — | -4.2% | +0.5% | +2.2% | +6.1% | -5.1% | -9.7% | -13.3% | -17.2% | -3.7% | -5.2% | -1.5% | -0.9% | -2.3% | +1.1% | +2.4% | +11.6% | +11.4% |
| Segment | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 |
|---|---|---|---|---|---|---|---|---|
| Reportable Segment | $14.38B | $14.38B | $14.27B | $15.69B | $0.66 | $0.67 | $0.66 | $0.66 |
| Total | $13.58B | $12.58B | $14.27B | $15.69B | $13.37B | $13.94B | $15.86B | $13.70B |